Company Overview of Capsugel, Inc.
Capsugel, Inc. manufactures and sells two-piece gelatin and hypromellose (HPMC) capsules for pharmaceutical, consumer healthcare, and dietary supplement industries worldwide. It offers hard gelatin, HPMC, acid-resistant, liquid, over-encapsulation, pre-clinical, pullulan, soft gelatin, fish gelatin, and pearlescent capsules. The company also provides dosage form development, formulation support, pre-clinical and clinical support, manufacturing and technical support, quality management support, regulatory assistance, and capsule encryption services. Its products are used in drug compounds, liquid-filled products, plant-based products, over-encapsulation, dry powder inhaler capsules, release t...
412 Mount Kemble Avenue
Morristown, NJ 07960
Founded in 1963
Key Executives for Capsugel, Inc.
Chief Executive Officer and President
Chief Marketing Officer and Senior Vice President
Global Director of Business Development
Compensation as of Fiscal Year 2014.
Capsugel, Inc. Key Developments
Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products
Aug 19 14
Capsugel and Cardax, Inc. announced a collaboration to develop unique astaxanthin products for the consumer health market. The goal of the collaboration is to commercialize proprietary formulations of nature-identical synthetic astaxanthin products with pharmaceutical-grade purity that will provide improved oral bioavailability compared with other astaxanthin products on the market. Astaxanthin is currently used as a specialized antioxidant. The astaxanthin products will be jointly developed using Capsugel's proprietary lipid multi-particulate (LMP) technology, which encapsulates dissolved or suspended active ingredients into spherical lipid matrix particles for oral dosage in capsules, sachets, suspensions or tablets. LMP technology utilizes a range of approved lipids to deliver the benefits of lipid-based formulations in multi-particulate format, including improved bioavailability, controlled release and effective taste-masking. The companies will seek a strategic partner for retail commercialization in the mass market. Specific business terms were not disclosed.
Capsugel, Inc. Launches a Capsule Design to Improve Adherence to Treatment Regimens for Patients with Difficulties Swallowing
Oct 22 13
Capsugel, Inc. launched an innovative capsule design to improve adherence to treatment regimens for patients with difficulties swallowing. These patients include babies, children, and older adults as well as patients with medical conditions such as Alzheimer's, Parkinson's, and Multiple Sclerosis. The new Coni-Snap(R) sprinkle capsule is expected to be available in 2014. Encapsulated drug multiparticulates, or "sprinkles", containing a defined dose of medicine that can be sprinkled on food or beverages is a known alternative for people with challenges swallowing. The major difficulty using standard capsules is that their strong locking mechanism requires sufficient grip strength and dexterity to reopen the capsule. Capsugel's Coni-Snap(R) sprinkle capsule was developed to provide easy-to-open capsules to caregivers and patients yet has a strong enough lock that allows for processing in the manufacturing and distribution chain. Capsugel tested the new design with caregivers to gauge usability, ease of opening, and user accuracy when sprinkling medications. More than 80 % of participants described the new design as "easy" or "very easy" to open. and, while most participants naturally opened the capsules horizontally, the evaluation determined that the most effective way to instruct users to open the capsules was with arrows printed directly on the capsule shell.
Similar Private Companies By Industry
Recent Private Companies Transactions